Cargando…

The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial

Background: The present clinical trial aimed to examine whether adherence to Dietary Approaches to Stop Hypertension (DASH) diet could improve lipid profile, the Pro-oxidant-antioxidant balance (PAB) as well as liver function in obese adults with non-alcoholic fatty liver disease (NAFLD). Methods: S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badali, Taghi, Arefhosseini, Sara, Rooholahzadegan, Farnaz, Tutunchi, Helda, Ebrahimi-Mameghani, Mehrangiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257571/ https://www.ncbi.nlm.nih.gov/pubmed/37309438 http://dx.doi.org/10.34172/hpp.2023.10

Ejemplares similares

The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial
por: Rooholahzadegan, Farnaz, et al.
Publicado: (2023)

Association of neck circumference-related indices with metabolic, atherogenic and liver function biomarkers in patients with non-alcoholic fatty liver disease: a cross-sectional study
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
por: Arefhosseini, Sara, et al.
Publicado: (2022)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie-Restricted Diet
por: Tutunchi, Helda, et al.
Publicado: (2023)

What are the optimal cut-off points of anthropometric indices for prediction of overweight and obesity? Predictive validity of waist circumference, waist-to-hip and waist-to-height ratios
por: Tutunchi, Helda, et al.
Publicado: (2020)

Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial
por: Tutunchi, Helda, et al.
Publicado: (2020)

The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults
por: Tutunchi, Helda, et al.
Publicado: (2020)

Effect of vitamin D supplementation in combination with weight loss diet on lipid profile and sirtuin 1 in obese subjects with vitamin D deficiency: a double blind randomized clinical trial
por: Aliashrafi, Soodabeh, et al.
Publicado: (2019)

Is the modified household food security survey (HFSS) questionnaire a practical tool for screening food insecurity? Evidence from northwest of Iran
por: Tutunchi, Helda, et al.
Publicado: (2020)

A Metabolic Enhancer Protects against Diet-Induced Obesity and Liver Steatosis and Corrects a Pro-Atherogenic Serum Profile in Mice
por: Platko, Khrystyna, et al.
Publicado: (2023)

Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial
por: Naeini, Fatemeh, et al.
Publicado: (2021)

Restoring the autonomic balance to reduce liver steatosis
por: Bruinstroop, Eveline, et al.
Publicado: (2019)

Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial
por: Ebrahimi-Mameghani, Mehrangiz, et al.
Publicado: (2016)

The effects of citrulline supplementation on meta-inflammation and insulin sensitivity in type 2 diabetes: a randomized, double-blind, placebo-controlled trial
por: Abbaszadeh, Fatemeh, et al.
Publicado: (2021)

Effect of a probiotic preparation (VSL#3) in critically ill patients: A randomized, double-blind, placebo-controlled trial (Pilot Study)
por: Ebrahimi-Mameghani, Mehrangiz, et al.
Publicado: (2013)

Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial
por: Sanaie, Sarvin, et al.
Publicado: (2014)

Integrative analysis of transcriptome and lipidome reveals fructose pro-steatosis mechanism in goose fatty liver
por: Wei, Rongxue, et al.
Publicado: (2023)

7: A SYSTEMATIC REVIEW ON VITAMIN D AND ANGIOGENESIS
por: Aliashrafi, Soodabeh, et al.
Publicado: (2017)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Automated assessment of steatosis in murine fatty liver
por: Sethunath, Deepak, et al.
Publicado: (2018)

Adiponectin as a potential biomarker of vascular disease
por: Ebrahimi-Mamaeghani, Mehrangiz, et al.
Publicado: (2015)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Atherogenic Index of Plasma (AIP) and Its Association with Fatty Liver in Obese Adolescents
por: Dağ, Hüseyin, et al.
Publicado: (2023)

Pro-oxidant antioxidant balance in patients with non-alcoholic fatty liver disease
por: Nobakht Motlagh Ghoochani, Bibi Fatemeh, et al.
Publicado: (2019)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Human liver organoid: modeling liver steatosis and beyond
por: Wei, Jinsong, et al.
Publicado: (2023)

38: COMPLICATIONS OF BROWN ADIPOSE TISSUE AND ITS ASSOCIATION WITH CARCINOGENESIS; A SYSTEMATIC REVIEW (PRELIMINARY DATA)
por: Jourabchi-Ghadim, Neda, et al.
Publicado: (2017)

The association of depression with metabolic syndrome parameters and malondialdehyde (MDA) in obese women: A case-control study
por: Vaghef-Mehrabani, Elnaz, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Chronological effects of atherogenic diets on the aorta, liver and spleen of rabbits.
por: Song, S. H., et al.
Publicado: (2000)

Total diet, individual meals, and their association with gastroesophageal reflux disease
por: Ebrahimi-Mameghani, Mehranghiz, et al.
Publicado: (2017)

Iodine status, and knowledge about iodine deficiency disorders in adolescent school girls aged 14-19 years, 2016
por: Heidari, Zahra, et al.
Publicado: (2019)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
por: Safari, Zahra, et al.
Publicado: (2023)

Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2022)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
por: Ahn, Sang Bong
Publicado: (2023)

Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions -Targeted siRNA delivery to pro-atherogenic endothelium in vivo
por: Chung, Jihwa, et al.
Publicado: (2016)

Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Taheri, Hoda, et al.
Publicado: (2020)

Correlation of Obesity and Overweight with Emotional-Behavioral Problems in Primary School Age Girls in Tabriz, Iran
por: Seyedamini, Bayanah, et al.
Publicado: (2012)

Focal Steatosis in the Beaver Tail Liver
por: Yıldırım, Mustafa
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v5jdfkog8ll8av1gu71t7e2uee